摘要 |
Stable, concentrated, non-aqueous solutions of doxorubicin HCl are provided containing doxorubicin HCl, citric acid and an antioxidant selected from sodium formaldehyde bisulfite, tert-butylhydroquinone and alpha -tocopherol (Vitamin E) in a solvent medium consisting of propylene glycol, 1,2-dihydroxybutane or 1,3-dihydroxypropane, or mixtures of such non-aqueous solvents with water. The solutions have an acceptable shelf-life of greater than 18 months at room temperature and can be diluted with water or other aqueous parenteral vehicles for parenteral administration. |